N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]carbamic acid 1,1-dimethylethyl ester

We are N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]carbamic acid 1,1-dimethylethyl ester CAS:1374507-23-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]carbamic acid 1,1-dimethylethyl ester
CAS.NO:  1374507-23-9
Synonyms:CO-1686 intermediate 3
Carbamic acid, N-[3-[[2-chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-, 1,1-dimethylethyl ester
2-Methyl-2-propanyl (3-{[2-chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino}phenyl)carbamate

Molecular Formula: C16H16ClF3N4O2
Molecular Weight:388.77200

Physical and Chemical Properties:
Density: 1.4±0.1 g/cm3
Boiling point:446.2±45.0 °C at 760 mmHg
Melting point: /
Flash point: 223.6±28.7 °C
Refractive index: 1.577

Specification:
Appearance:White powder
Purity:≥99.0%

Packing:
 25kg 1 cardboard drum or according to customer specified requirements
Storage:The product should be sealed and stored in a dry and cool place.
Application: Intermediates of Rociletinib CAS:1374640-70-6.

Related News: Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Vinyltriacetoxysilane Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.2-Acetylpyridine Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.7-chloroheptan-1-ol CAS:55944-70-2 Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.